Recent progress in engineered extracellular vesicles and their biomedical applications

被引:4
作者
Mazahir, Farhan [1 ]
Yadav, Awesh K. [1 ]
机构
[1] Natl Inst Pharmaceut Educ & Res Raebareli, Dept Pharmaceut, Transit Campus,Bijnor Sisendi Rd, Lucknow 226002, India
关键词
Extracellular vesicles; Drug delivery; Cancer therapy; Neurodegenerative disorders; Vaccine production; Tuberculosis; MICROFLUIDIC DEVICE; DRUG-DELIVERY; ACOUSTIC SEPARATION; CANCER-THERAPY; EXOSOMES; PROTEINS; NANOPARTICLES; STRATEGIES; QUANTIFICATION; ENRICHMENT;
D O I
10.1016/j.lfs.2024.122747
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aims: To present the recent update on the isolation, engineering techniques for extracellular vesicles, limitations associated with different isolation techniques, different biomedical applications, and challenges of engineered extracellular vesicles for the benefit of researchers from academic, industry, etc. Materials and methods: Peer-reviewed articles from most recognized journals were collected, and presented information was analyzed to discuss collection, chemical, electroporation, cellular, and membrane surface engineering to design extracellular vesicles for various therapeutic applications. In addition, we present the applications and limitations of techniques for the collection of extracellular vesicles. Key findings: There is a need for isolation techniques with the gold standard. However, advanced extracellular vesicle isolation techniques showed improved recovery, and purity of extracellular vesicles. Tumor therapy is a major part of the therapy section that illustrates the role of engineered extracellular vesicles in synergetic therapy such as phototherapy, theragnostic, and delivery of genetic materials. In addition, extracellular vesicles have shown their potential in the treatment of retinal disorders, neurodegenerative disease, tuberculosis, osteoporosis, inflammatory bowel disease, vaccine production, and wound healing. Significance: Engineered extracellular vesicles can deliver cargo to the specific cells, elicit an immune response and could be used for the development of the vaccines in the future. However, the progress is at the initial stage. Overall, this review will provide a comprehensive understanding and could serve as a reference for researchers in the clinical translation of engineered extracellular vesicles in different biomedical fields.
引用
收藏
页数:26
相关论文
共 299 条
  • [91] Rapid isolation and enrichment of extracellular vesicle preparations using anion exchange chromatography
    Heath, Nikki
    Grant, Lois
    De Oliveira, Taiana Maia
    Rowlinson, Rachel
    Osteikoetxea, Xabier
    Dekker, Niek
    Overman, Ross
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [92] Exosomal delivery of therapeutic modulators through the blood-brain barrier; promise and pitfalls
    Heidarzadeh, Morteza
    Gursoy-Ozdemir, Yasemin
    Kaya, Mehmet
    Eslami Abriz, Aysan
    Zarebkohan, Amir
    Rahbarghazi, Reza
    Sokullu, Emel
    [J]. CELL AND BIOSCIENCE, 2021, 11 (01)
  • [93] Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain
    Hemler, ME
    [J]. ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2003, 19 : 397 - 422
  • [94] Development of surface engineered antigenic exosomes as vaccines for respiratory syncytial virus
    Hong, Suyeon
    Ruan, Shaobo
    Greenberg, Zachary
    He, Mei
    McGill, Jodi L.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [95] Houben RMGJ, 2022, LANCET RESP MED, V10, P537, DOI 10.1016/S2213-2600(22)00184-9
  • [96] Engineered exosomes and composite biomaterials for tissue regeneration
    Hu, Weikang
    Wang, Wang
    Chen, Zesheng
    Chen, Yun
    Wang, Zijian
    [J]. THERANOSTICS, 2024, 14 (05): : 2099 - 2126
  • [97] Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
    Hua, Susan
    de Matos, Maria B. C.
    Metselaar, Josbert M.
    Storm, Gert
    [J]. FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [98] Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer
    Huang, Lanxiang
    Rong, Yuan
    Tang, Xuan
    Yi, Kezhen
    Qi, Peng
    Hou, Jinxuan
    Liu, Weihuang
    He, Yuan
    Gao, Xing
    Yuan, Chunhui
    Wang, Fubing
    [J]. MOLECULAR CANCER, 2022, 21 (01)
  • [99] Research Advances of Engineered Exosomes as Drug Delivery Carrier
    Huang, Lianghui
    Wu, Enguang
    Liao, Jiawei
    Wei, Zongyi
    Wang, Jin
    Chen, Zhenhua
    [J]. ACS OMEGA, 2023, 8 (46): : 43374 - 43387
  • [100] Continuous particle separation through deterministic lateral displacement
    Huang, LR
    Cox, EC
    Austin, RH
    Sturm, JC
    [J]. SCIENCE, 2004, 304 (5673) : 987 - 990